Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?

被引:149
作者
Bagis, S
Tamer, L
Sahin, G
Bilgin, R
Guler, H
Ercan, B
Erdogan, C
机构
[1] Mersin Univ, Sch Med, Dept Phys Med & Rehabil, Mersin, Turkey
[2] Mersin Univ, Sch Med, Dept Biochem, Mersin, Turkey
[3] Cukurova Univ, Art & Sci Fac, Dept Biochem, Adana, Turkey
关键词
antioxidant; fibromyalgia; oxidant;
D O I
10.1007/s00296-003-0427-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of free radicals in fibromyalgia is controversial. In this study, 85 female patients with primary fibromyalgia and 80 age-, height-, and weight-matched healthy women were evaluated for oxidant/antioxidant balance. Malondialdehyde is a toxic metabolite of lipid peroxidation used as a marker of free radical damage. Superoxide dismutase is an intracellular antioxidant enzyme and shows antioxidant capacity. Pain was assessed by visual analog scale. Tender points were assessed by palpation. Age, smoking, body mass index (BMI), and duration of disease were also recorded. Malondialdehyde levels were significantly higher and superoxide dismutase levels significantly lower in fibromyalgic patients than controls. Age, BMI, smoking, and duration of disease did not affect these parameters. We found no correlation between pain and number of tender points. In conclusion, oxidant/antioxidant balances were changed in fibromyalgia. Increased free radical levels may be responsible for the development of fibromyalgia. These findings may support the hypothesis of fibromyalgia as an oxidative disorder.
引用
收藏
页码:188 / 190
页数:3
相关论文
共 23 条
[1]  
ABRAHAM G E, 1992, Journal of Nutritional Medicine, V3, P49, DOI 10.3109/13590849208997961
[2]  
Ali M, 1999, J INTEGR MED, V3, P17
[3]   Role of endogenous and exogenous antioxidants in the defence against functional damage and lipid peroxidation in rat liver mitochondria [J].
Augustin, W ;
Wiswedel, I ;
Noack, H ;
Reinheckel, T ;
Reichelt, O .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1997, 174 (1-2) :199-205
[4]  
BENGTSSON A, 1986, SCAND J RHEUMATOL, V15, P1
[5]   Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? [J].
Dib, M ;
Garrel, C ;
Favier, A ;
Robin, V ;
Desnuelle, C .
JOURNAL OF NEUROLOGY, 2002, 249 (04) :367-374
[6]  
DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
[7]  
Eisinger J, 1996, MAGNESIUM RES, V9, P313
[8]  
Eisinger J., 1994, Magnesium Research, V7, P285
[9]  
EISINGER J, 1994, J AM COLL NUTR, V13, P144
[10]  
FASSBENDER HG, 1973, Z RHEUMAFORSCH, V32, P355